ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 146

Age-Related Differences in Neuronal High Mobility Group Box-1 and Resolvin D1 Receptors in Collagen-Induced Arthritis

Tracy Wilson-Gerwing and Alan Rosenberg, Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Arthritis, Inflammation, juvenile arthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Genetics and Pathogenesis Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: More thorough understanding of age-related molecular interactions that drive inflammation and inflammatory pain is required to help guide evidenced-based, age appropriate treatment strategies that improve arthritis care. Our earlier studies indicate that age is an important determinant of collagen-induced arthritis (CIA) progression and resolution. This study characterized age-related differences in an inflammatory pain pathway involving pro-inflammatory high mobility box 1 protein (HMGB1) and pro-resolution resolvin among different age groups of rats with and without arthritis.

Methods:  Juvenile (5 wks old) and young adult (13 wks old) male Wistar rats were immunized with an emulsion of bovine type II collagen/incomplete Freund’s adjuvant. Naïve juvenile and adult rats served as controls. For each animal, the Maximum Daily Arthritis Score (MDAS) was recorded. Fourteen days after arthritis onset, animals were euthanized and blood and tissues collected. Dorsal root ganglia immunohistochemistry assessed pro-inflammatory high mobility group box-1 (HMGB1), receptor for advanced glycation end products (RAGE) and the resolvin D1 receptors G-protein coupled receptor 32 (GPR32) and formyl peptide receptor 2 (FPR2).

Results: The MDAS for juvenile rats with CIA were significantly lower than the adult rats with CIA (3.96 + 0.17 and 5.25 + 0.16 respectively; p<0.0001). During the first week after onset of CIA, adult rats had a slightly higher MDAS than juvenile rats (p=0.04). During the second week of CIA, the MDAS for juvenile rats decreased (p=0.03) while the MDAS for adult rats increased significantly (p=0.002). At the end of the second week of CIA, adult rats had a significantly higher MDAS than juveniles (p<0.0001).

Adult naïve rats had significantly higher percentages of neurons expressing HMGB1 (p<0.0001) and RAGE (p=0.02) than juvenile naïve rats. Two weeks after CIA onset, percentage of neurons positive for HMGB1 (p<0.0001) and RAGE (p=0.0002) were significantly higher in the adult CIA group compared to the juvenile naïve group. In contrast, Juvenile naïve rats have significantly higher percentages of GPR32 (p=0.02) and FPR2 (p=0.04) expressing neurons than adult naïve rats. After two weeks, Juvenile CIA rats also had a higher percentage of neurons expressing GPR32 than the Adult CIA rats (p=0.02). No differences in the percentage of neurons expressing FPR2 were observed between Juvenile CIA and Adult CIA rats.

Conclusion:  Results indicate age-related differences in arthritis severity are related to the balance between HMGB1 and resolvins and their respective receptors with the balance favoring promotion of inflammation in adults associated with higher levels of HMGB1 and lower levels of resolvin receptors. Juveniles have more available resolvin receptors that may impede transition from acute to chronic arthritis in this model. We postulate that anti-inflammatory effects of endongenous resolvins are mediated by impeding production of HMGB1 and/or HMGB1 binding to its receptors.


Disclosure: T. Wilson-Gerwing, None; A. Rosenberg, None.

To cite this abstract in AMA style:

Wilson-Gerwing T, Rosenberg A. Age-Related Differences in Neuronal High Mobility Group Box-1 and Resolvin D1 Receptors in Collagen-Induced Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/age-related-differences-in-neuronal-high-mobility-group-box-1-and-resolvin-d1-receptors-in-collagen-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/age-related-differences-in-neuronal-high-mobility-group-box-1-and-resolvin-d1-receptors-in-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology